06:47 EDT Pfizer (PFE): Current guidance assumes no share repurchases in 2025
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s Financial Outlook: Hold Rating Amidst Short-Term Challenges and Long-Term Potential
- Notable companies reporting before tomorrow’s open
- Pfizer call volume above normal and directionally bullish
- Eli Lilly, Pfizer, Amgen – Trump’s 25% Pharma Tariffs Could Drain $51B Annually
- ‘Regulatory Headwinds Set to Bite,’ Says Top Analyst on Novavax Stock (NVAX)